Solifenacin
Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- SPE2D2-25-R-0011
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Jayne Do jayne.do@dla.mil (445) 737-5764
- Jason Wray jason.wray@dla.mil (215) 737-0614
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to issue a national requirements contract for Solifenacin Succinate tablets in 5MG and 10MG strengths, packaged in 30 and 90 count bottles. This will be a fully competitive, unrestricted acquisition using FAR Part 12 for commercial items. The contract will be structured as a firm-fixed price, requirements-type contract with a one-year base period and four potential one-year option periods. The primary objective is to establish a national supply source for Solifenacin that can support Department of Defense, Indian Health Service, and Bureau of Prisons customers through the DLA prime vendor program. Interested parties are advised to contact Jayne Do at Jayne.Do@dla.mil for questions and to set up automated notifications, with the current projected solicitation date set for April 2025.
The procurement is not designated with any specific set-aside, meaning all sources may submit proposals for consideration. While no incumbent contractors are mentioned, the contract will be solicited through the DLA Bid Board System (DIBBS) and SAM.gov. Annual usage estimates will be provided in the Schedule of Supplies section of the forthcoming solicitation. The contract aims to create a comprehensive pharmaceutical supply arrangement with specific focus on Solifenacin tablets. DLA reserves the right to issue the solicitation before or after the projected April 2025 date, providing flexibility in the procurement timeline. The pharmaceutical preparation falls under NAICS category 325412 and PSC category 6505 for drugs and biologicals, indicating a specialized medical supply contract.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Solifenacin. Procurement details follow.
Solifenacin Succinate 5MG and 10MG tablets in 30 and 90 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Indian Health Service and Bureau of Prisons customers through the DLA prime vendor program. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov/. Interested parties should contact Jayne Do at Jayne.Do@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is April of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Solifenacin Award | Award Notice | |
| Solifenacin | Solicitation | |
| Solifenacin | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity